Recommended dosages can vary between brands
GLP-1 and GLP-1/GIP receptor agonist medications are clinically studied for their approved indications
Often noncancerous, the dark line usually goes away once you treat the underlying medical condition
Table of Contents Why diabetes visits must change in the GLP-1 era Key priorities in a GLP-1 era clinic workflow What to focus on in a 15-minute visit Balancing labs, lifestyle, and medications Building a sustainable workflow for care teams Why Diabetes Visits Must Change in the GLP-1 Era GLP-1 medications such as semaglutide and tirzepatide influence multiple metabolic pathways at once
However at minimum, Canadians living with obesity who have a BMI over 30 OR with a BMI 27-30 who have a medical comorbidity like diabetes, high blood pressure or high cholesterol
How Long Side Effects May Last There is no single answer, but common patterns include: mild nausea and fullness improving after a few weeks bloating and constipation improving with food and water changes burping and heartburn improving when you slow down eating Some people have small waves of symptoms that return when they move up to a higher dose
